Presentation TCT 2014 Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Louis B. Jacques September 15, 2014
Presentation TCT 2014 Regulation of Cardiovascular Devices in Europe: A Need for Change Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Angeles Alonso Garcia September 15, 2014
Presentation TCT 2014 Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Jack C. Lewin September 15, 2014
Presentation TCT 2014 Keynote Lecture III: Updates and Accomplishments of the New CDRH Early Feasibility Program Presenter: Andrew Farb, Juan F. Granada, Donald Cutlip September 15, 2014
Presentation TCT 2014 Statistical and Regulatory Challenges with Big Data and National Registries: Is Propensity Adjustment Enough? FDA Considerations Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Gregory Campbell September 15, 2014
Presentation TCT 2014 Are We Ready for Radical Changes in Medical Device Clinical Trial Designs? Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert M. Califf September 15, 2014
Presentation TCT 2014 CDRH Efforts to Improve the Ecosystem for Clinical Trials Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Owen Faris September 15, 2014
Presentation TCT 2014 Keynote Lecture II: Clinical Research in the United States Current Realities and How the Tide Can Turn Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert A. Harrington September 15, 2014
Presentation TCT 2014 Keynote Lecture I: The New FDA-CDRH: Lessons Learned, Current Challenges, and Future Vision Presenter: Matthew G. Hillebrenner, Martin B. Leon, Aaron V. Kaplan, William H. Maisel September 15, 2014
News Industry News REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System September 15, 2014
News Industry News New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients September 15, 2014
News Industry News New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents September 15, 2014
News Industry News New Study Evaluates “Triple Therapy” Regimens After Drug-Eluting Stenting in Patients Requiring Oral Anticoagulation September 15, 2014
News Industry News Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium September 15, 2014
News Conference News TCT 2014 MOC Program Continues to Stir Controversy, Elicit Debate September 15, 2014
News Industry News Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients September 15, 2014
News Industry News Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction September 15, 2014
News Industry News Randomized Trial of Intravascular Ultrasound-Guided Intervention Demonstrates Improved Outcomes for Patients with Chronic Total Coronary Artery Occlusion September 14, 2014
News Industry News New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons in Patients with Drug-Eluting Stent Restenosis September 14, 2014
News Industry News New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI September 14, 2014